Dietary Modulation of Cholesterol Metabolism
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Howard Hughes Medical Institute
Other organizations : University of Zurich, University of Washington
Variable analysis
- 0.5% (w/w) CA in Teklad 7001 or Teklad 2019 base diet
- 2% (w/w) cholestyramine (Sigma) diet on AIN93G
- 0.2% (w/v) sodium deoxycholic acid (Sigma) dissolved in sterile water
- Tamoxifen (Sigma) treatment by intraperitoneal (IP) injection or given in chow (Envigo TD.130858)
- Diphtheria toxin (Sigma) injected retro-orbitally
- GW4064 (Selleck Chem) dissolved in DMSO, resuspended in sterile methycellulose and given IP at 100 mg/kg body weight
- Labelling assessed 24 hrs after last injection/removal of diet
- Teklad 7001 or Teklad 2019 base diet
- AIN93G diet
- Sterile water
- Ethanol/cremaphore
- Sterile PBS
- Sterile methycellulose
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!